View Online


ChemRxiv


In light of the current outbreak of a novel coronavirus (2019–nCoV), ChemRxiv would like to share this collection of preprints* on COVID-19. Chemistry has a key role to play in understanding everything from viral structure to pathogenesis, isolation of vaccines and therapies, as well as in the development of materials and techniques used by basic researchers, virologists, and clinicians.

ChemRxiv is openly accessible, with no subscription fees for readers and no submission charges for authors. We encourage you to read and share this collection with colleagues and also invite you to share your research with a global community of scientists by posting your COVID-19 research on ChemRxiv.

Read a Selection of COVID-19 Research:

A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry

Mohamed El-Tholoth, Haim H. Bau, and Jinzhao Song

Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface

Micholas Smith and Jeremy C. Smith

Homology Models of the Papain-Like Protease PLpro from Coronavirus 2019-nCoV

Martin Stoermer

COVID-19 Disease: ORF8 and Surface Glycoprotein Inhibit Heme Metabolism by Binding to Porphyrin

Wenzhong Liu and Hualan Li

Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations

Junjie Zou, Jian Yin, Lei Fang, Mingjun Yang, Tianyuan Wang, Weikun Wu, Peiyu Zhang

Virtual Screening of an FDA Approved Drugs Database on Two COVID-19 Coronavirus Proteins

Alessandro Contini

Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study

Junmei Wang

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates

Yu Wai Chen, Chin-Pang Yiu, and Kwok-Yin Wong

Homology Models of Coronavirus 2019-nCoV 3CLpro Protease

Martin Stoermer

Molecular Docking Study of Novel COVID-19 Protease with Low Risk Terpenoides Compounds of Plants

Neda Shaghaghi


*Please note that ChemRxiv preprints have not been peer-reviewed and as such should be read with additional scrutiny. In the event that these preprints have subsequently appeared in a peer-reviewed journal, a link denoting this will appear on the page.

Share your research with the global community of scientists at ChemRxiv.org
ACS Materials Letters
Follow on Twitter Follow on Facebook




Copyright © 2020 American Chemical Society
1155 Sixteenth Street NW | Washington, DC 20036

This email was sent to cma@acsi.info because it relates to topics in which you expressed an interest
or ACS Publications services you have used.

Unfollow "ChemRxiv" updates.

Customize your preferences or stop all emails from ACS Publications.

Worth remembering: Any actions taken only relate to the email address stated above.
If you forward this email you may be sharing your personal information with others.
Changes will not impact account, service or bill-related communications.

ACS Privacy Policy